Surgical management depending on OA severity involves intraarticular injection with anti-inflammatory agents, arthrocentesis, arthroscopy, arthroplasty and joint replacements.
The authors of this well formatted systematic review attempted to demonstrate the effectiveness of different therapies for the treatment of TMJ OA. The review has a defined purpose, inclusion and exclusion criteria and types of outcome measures. However, they didn't clearly define limits for short-term or long-term outcome measures for specified therapies. They classified the participants to be adults, legally defined as being greater than 18 years of age.
Prevalence of OA in 18-year-olds can be questionable as they may still be in a condylar growth phase. OA increases with age. Length of time for the interventions is important in prevention of disease progression for a younger vs elderly patient. Gender/hormonal effects
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were not looked at because of extent of heterogeneity amongst the few qualifying studies.
The authors found that there were a large number of studies that included mixed groups with participants diagnosed with TMJ OA and other TMJ disorders. It should be noted that perhaps the OA doesn't occur alone and is a co-morbid disease process associated with other joint dysfunctions or conditions. OA could therefore be the end result of intra-capsular derangements and thus must be looked at concomitantly with other associated conditions. This may be a reason for the limited availability of the data.
The authors sorted through databases where they would find the best quality of studies and RCTs and excluded studies that were not RCTs. They hand selected specific journals to include in their search that were not found in the databases searched. They attempted to search for unpublished data by contacting authors of conducted studies for further information. They also included all languages and found translators to ensure that all available papers were included in this study. Two independent reviewers assessed the quality of the research by graded criteria and discussed any disagreements with a third party consultant.
The authors were limited by the available randomised clinical trials (RCTs) and only three studies qualified for this review with diverse interventions making it difficult to assess any long-term recommendation in therapeutic outcomes. Use of standardisation of diagnostic criteria, as RDC/TMD 1-3 are needed for research comparisons between studies. Many studies were excluded because diagnosis wasn't based on this standard. There was found to be limited availability of the trials with all therapeutic modalities. It is unclear how they reached a total of three studies or four full-text articles with one study awaiting assessment. There was no further mention of the one study awaiting assessment.
Of the three included studies two did not contain control groups to evaluate the benefits of therapy over no treatment at all. All three considered pain/tenderness of TMJ and muscles of mastication or mandibular movement as outcomes. Not all measured joint sounds or radiographic changes on CT scans. Not all parameters of outcomes were tested in the three studies, limiting the availability of data for this review and making comparison between nonsurgical and minimally invasive interventions inapplicable. Therapeutic targets (long term outcomes) were unspecified and sequential therapy was not given any mention.
Only between 29-45 participants were included in these trials.
Appropriately, all participants underwent CT scans for assessments. Weakness with biases within the studies varied with one demonstrating reporting bias and others with uncertain biases in selection, performance and detection.
They were unable to combine the studies yet they conducted statistical analysis of the individual studies that were not statistically significant to prove any one therapeutic advantage over another.
The surgical outcomes were not available for assessment and thus no conclusion can be made of their therapeutic benefit. There is insufficient evidence to conclude any one therapeutic advantage over another. From the results of this review all therapies were equally effective in pain reduction. In totality there is lack of evidence for assessment of all outcomes listed in this review by the authors.
In two of the reviewed studies only pain and jaw movement were assessed and long-term outcomes were not available to assess factors such as prevention/progression of disease and quality of life improvements. Reports of side effects/intolerances of the diclofenac and occlusal splints could not be compared to the side effects/intolerances of other treatment modalities either because data were not available or because lack plausibility of comparison of effects unrelated to other therapies. This issue was not discussed in this review.
Application of these limited therapeutic modalities to TMJ OA cannot be conclusively recommended, as harm was not assessed and benefits were short term. 
selective inclusion criteria to increase the internal validity of findings, the authors did not consider some disease-related methodological shortcomings leading to the exclusion of potentially clinically-relevant investigations, thus creating a super-selected pool of reviewed papers with low external validity. 6 The literature on temporomandibular disorders (TMD) suggested that multiple diagnoses are frequent, 7 and performing an 'ideal' study on 'pure' OA patients, as suggested by the authors, may be difficult and not logical from a clinical viewpoint. So, the exclusion criteria indicated by the authors as 'other TMJ disorders than OA', or 'did not provide separate data for participants with TMJ OA', which were responsible for the wide majority of the excluded papers (31 out of 40 studies) need to be re-appraised with further assessment performed by reviewers with a more specific know-how of the TMJ disorders literature. Also, the assessment of the complex multimodal pain experience, taking into account the so-called RDC/TMD axis II at the time of group randomisation in RCTs, is a fundamental requisite for a real matching of any study groups. Moreover, it must be borne in mind that surgical interventions are hardly comparable with other treatment interventions in a true clinical trial for obvious methodological and ethical reasons.
All these observations suggest that, as a general remark, the conclusions of all literature reviews are strongly influenced by the inclusion criteria for study selection that, in turn, depend on the specific clinical expertise of the examiners managing the data. For this reason, it is not surprising that some lower-level, more narratively-oriented, systematic reviews are still widely appreciated by the researchers belonging to the specific field of interest. Having made these observations, there are no doubts that the authors should be complimented for their ambitious attempt to summarise such a vast issue, and this review may represent a stimulus for performing higher-level investigations comparing the different strategies to manage TMJ osteoarthritis.
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